Business Description
Compare
Compare
Traded in other countries / regions
VILINBIO.India IPO Date
2023-06-30Description
Vilin Bio Med Ltd is engaged in the manufacturing and trading of pharmaceutical and allied products. It caters to both patients and healthcare providers around the world. The company's product portfolio includes a diverse range of pharmaceutical products such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta-lactam tablets and capsules, and nutritional food supplements. Its specialized brand divisions include Skinvil, Good Choice, Oravil, and others. Geographically, the company derives the maximum revenue from India, with the rest coming from exports.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.14 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 2406.45 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 8.43 | |||||
Beneish M-Score | -1.13 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 50.4 | |||||
3-Year EBITDA Growth Rate | 6.8 | |||||
3-Year EPS without NRI Growth Rate | 13.1 | |||||
3-Year Book Growth Rate | 34.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 75.47 | |||||
9-Day RSI | 63 | |||||
14-Day RSI | 57.01 | |||||
3-1 Month Momentum % | -10.32 | |||||
6-1 Month Momentum % | 21.89 | |||||
12-1 Month Momentum % | 58.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.25 | |||||
Quick Ratio | 3.13 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 74.04 | |||||
Days Sales Outstanding | 124.63 | |||||
Days Payable | 30.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3 | |||||
Shareholder Yield % | 2.02 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 12.08 | |||||
Operating Margin % | 8.12 | |||||
Net Margin % | 5.45 | |||||
EBITDA Margin % | 8.77 | |||||
FCF Margin % | -4.16 | |||||
OCF Margin % | 0.67 | |||||
ROE % | 6.91 | |||||
ROA % | 5.67 | |||||
ROIC % | 6.3 | |||||
3-Year ROIIC % | 1.56 | |||||
ROC (Joel Greenblatt) % | 15.21 | |||||
ROCE % | 10.25 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 35.48 | |||||
PE Ratio without NRI | 35.48 | |||||
Price-to-Owner-Earnings | 333.58 | |||||
PEG Ratio | 1.52 | |||||
PS Ratio | 1.93 | |||||
PB Ratio | 2.4 | |||||
Price-to-Tangible-Book | 2.4 | |||||
Price-to-Operating-Cash-Flow | 269.28 | |||||
EV-to-EBIT | 25.26 | |||||
EV-to-EBITDA | 23.41 | |||||
EV-to-Revenue | 2.05 | |||||
EV-to-FCF | -49.3 | |||||
Price-to-GF-Value | 0.6 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.4 | |||||
Price-to-Graham-Number | 1.89 | |||||
| Price-to-Net-Current-Asset-Value | 3.27 | |||||
Earnings Yield (Greenblatt) % | 3.96 | |||||
FCF Yield % | -1.99 | |||||
Forward Rate of Return (Yacktman) % | 17.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vilin Bio Med Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 325.99 | ||
| EPS (TTM) (₹) | 1.26 | ||
| Beta | -0.5941 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.85 | ||
| Volatility % | 76.58 | ||
| 14-Day RSI | 57.01 | ||
| 14-Day ATR (₹) | 1.239654 | ||
| 20-Day SMA (₹) | 42.5725 | ||
| 12-1 Month Momentum % | 58.36 | ||
| 52-Week Range (₹) | 18.95 - 54.4 | ||
| Shares Outstanding (Mil) | 15.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vilin Bio Med Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vilin Bio Med Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vilin Bio Med Ltd Frequently Asked Questions
What is Vilin Bio Med Ltd(NSE:VILINBIO)'s stock price today?
The current price of NSE:VILINBIO is ₹44.70. The 52 week high of NSE:VILINBIO is ₹54.40 and 52 week low is ₹18.95.
When is next earnings date of Vilin Bio Med Ltd(NSE:VILINBIO)?
The next earnings date of Vilin Bio Med Ltd(NSE:VILINBIO) is .
Does Vilin Bio Med Ltd(NSE:VILINBIO) pay dividends? If so, how much?
Vilin Bio Med Ltd(NSE:VILINBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vilin Bio Med Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers